S. Kilickap Et Al. , "ANTITUMOR AND ANTIANGIOGENIC ACTIVITY OF SORAFENIB ON COLORECTAL CANCER," 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , vol.23, Vienna, Austria, pp.220, 2012
Kilickap, S. Et Al. 2012. ANTITUMOR AND ANTIANGIOGENIC ACTIVITY OF SORAFENIB ON COLORECTAL CANCER. 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , (Vienna, Austria), 220.
Kilickap, S., Altun, A., Babacan, N. A., Ataseven, H., & Kaya, T., (2012). ANTITUMOR AND ANTIANGIOGENIC ACTIVITY OF SORAFENIB ON COLORECTAL CANCER . 37th Congress of the European-Society-for-Medical-Oncology (ESMO) (pp.220). Vienna, Austria
Kilickap, S. Et Al. "ANTITUMOR AND ANTIANGIOGENIC ACTIVITY OF SORAFENIB ON COLORECTAL CANCER," 37th Congress of the European-Society-for-Medical-Oncology (ESMO), Vienna, Austria, 2012
Kilickap, S. Et Al. "ANTITUMOR AND ANTIANGIOGENIC ACTIVITY OF SORAFENIB ON COLORECTAL CANCER." 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , Vienna, Austria, pp.220, 2012
Kilickap, S. Et Al. (2012) . "ANTITUMOR AND ANTIANGIOGENIC ACTIVITY OF SORAFENIB ON COLORECTAL CANCER." 37th Congress of the European-Society-for-Medical-Oncology (ESMO) , Vienna, Austria, p.220.
@conferencepaper{conferencepaper, author={S. Kilickap Et Al. }, title={ANTITUMOR AND ANTIANGIOGENIC ACTIVITY OF SORAFENIB ON COLORECTAL CANCER}, congress name={37th Congress of the European-Society-for-Medical-Oncology (ESMO)}, city={Vienna}, country={Austria}, year={2012}, pages={220} }